跳至主要内容
临床试验/NCT01662414
NCT01662414已完成4 期

Effect of Undenatured Cysteine-Rich Whey Protein Isolate (HMS 90®) in Patients With Parkinson's Disease: Changes in Biomarkers of Oxidative Stress, Profiles of Plasma Amino Acids and Their Derivatives and Brain Function

Chulalongkorn University2 个研究点 分布在 1 个国家目标入组 38 人开始时间: 2011年4月最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
38
试验地点
2
主要终点
Concentrationsrofiles of plasma amino acids and their derivatives Brain function by PET-Scan

研究概览

简要总结

This is a double-blind, placebo-controlled, Phase IV trial , comparing HMS 90® versus placebo (soy protein) as add-on (adjuvant) therapy in subjects with idiopathic Parkinson's Disease.

The principal objective is to evaluate the changes in biomarkers of oxidative stress and,plasma amino acids, as well as improvement of clinical symptoms and brain function

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
30 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects with Idiopathic Parkinson's Disease
  • Subjects who are willing and able to participate in the trial and has provided written, informed consent.

排除标准

  • Subjects who are allergic to Whey protein (HMS 90®).
  • Subjects who are treated with chemotherapy .
  • Subjects with any history of neurodegenerative diseases, e.g., Alzheimer's disease.
  • Subjects with history of diabetes. 4.
  • Subjects with abnormal liver function test

结局指标

主要结局

Concentrationsrofiles of plasma amino acids and their derivatives Brain function by PET-Scan

时间窗: 6 months

Biomarkers of oxidative stress, i.e., plasma glutathione (reduced and oxidized forms), urinary 8-hydroxydeoxyguanosine, and urinary total antioxidant status

时间窗: 6 months

次要结局

  • Unified Parkinson's Disease Rating Scale (UPDRS) Section II (ADL) score change baseline to week 24(6 months)
  • • Clinical Global impression (CGI) - Change scale score, change from baseline to week 24(6 months)
  • Nutrition Questionnaire score change baseline to week 24(6 months)
  • Unified Parkinson's Disease Rating Scale (UPDRS) Section III (motor) score change from baseline to week 24(6 months)
  • • Clinical Global impression (CGI) - Severity scale score change from baseline to week 24(6 months)
  • • Parkinson's Disease quality of life questionnaire score change from baseline to week 24(6 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验